Strategy

The Directors believe that technological advancements and discoveries in the pharmaceutical and biotechnology sectors are growing, and that the opportunity exists to acquire an existing company with significant intellectual property in the pharmaceutical and biotechnology sectors as technological advances enable the development of new products and services to seek to prevent, diagnose and treat a multitude of conditions.

The Company will look to acquire a target company that possesses proprietary technologies as well as components of contemporary diagnostic, prevention and treatment development.

Opportunities may be derived from research centres as well as from corporate entities and start-up companies. The Company will look to select, develop and commercialise promising technologies to a level at which the technology becomes attractive to institutional investors or pharmaceutical and biotechnology companies.